» Articles » PMID: 35677020

Outcomes and Return-to-Sport Rates for Elite Athletes With Femoral Retroversion Undergoing Hip Arthroscopy: A Propensity-Matched Analysis With Minimum 2-Year Follow-up

Overview
Specialty Orthopedics
Date 2022 Jun 9
PMID 35677020
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Return to sports (RTS) and patient-reported outcomes (PROs) for elite athletes with femoral version abnormalities undergoing hip arthroscopy have not been well established.

Purposes: To (1) report minimum 2-year PROs and RTS rates in elite athletes with femoral retroversion who underwent primary hip arthroscopy and (2) compare clinical results to those of a propensity-matched control group of elite athletes with normal femoral version who underwent primary hip arthroscopy.

Study Design: Cohort study; Level of evidence, 3.

Methods: Data were prospectively collected and retrospectively reviewed for elite (professional and collegiate) athletes with femoral version <5°, as measured on magnetic resonance imaging scans, who underwent hip arthroscopy for femoroacetabular impingement syndrome between March 2010 and April 2018. Inclusion criteria were preoperative and minimum 2-year follow-up PROs for the modified Harris Hip Score, Nonarthritic Hip Score, Hip Outcome Score-Sports Specific Subscale (HOS-SSS), and visual analog scale for pain. Exclusion criteria were Tönnis grade >1, hip dysplasia, and previous ipsilateral hip surgery or conditions. Rates of achieving the minimal clinically important difference (MCID), Patient Acceptable Symptom State (PASS), and maximum outcome improvement satisfaction threshold were recorded in addition to RTS. Athletes with retroversion were propensity matched in a 1:2 ratio to elite athletes with normal femoral version (5°-20°) for comparison.

Results: A total of 33 elite athletes (33 hips) with femoral retroversion who underwent hip arthroscopy met the inclusion criteria, and follow-up was available for 30 hips in 30 athletes (90.9%) at an average of 36.1 ± 25.6 months. Elite athletes with femoral retroversion demonstrated significant improvements in all recorded PROs, achieved the MCID and PASS for the HOS-SSS at high rates (86.7%), and returned to sports at a rate of 83.3%. PROs, rates of achieving MCID and PASS for the HOS-SSS, and RTS rates were similar between the study and propensity-matched control group.

Conclusion: Elite athletes with femoral retroversion undergoing primary hip arthroscopy demonstrated favorable PROs and high RTS rates at a minimum 2-year follow-up. These results were comparable with those of a propensity-matched control group of elite athletes with normal femoral version.

Citing Articles

Return to Sport Following Arthroscopic Management of Femoroacetabular Impingement: A Systematic Review.

Lucenti L, Maffulli N, Bardazzi T, Saggini R, Memminger M, Simeone F J Clin Med. 2024; 13(17).

PMID: 39274432 PMC: 11395971. DOI: 10.3390/jcm13175219.


Femoral version and its clinical relevance in adult hip preservation surgery for developmental dysplasia of the hip.

Su Y, Chen K, Wu J, Zhu J, Chen X EFORT Open Rev. 2024; 9(9):873-882.

PMID: 39222332 PMC: 11457817. DOI: 10.1530/EOR-23-0145.


Survivorship, Outcomes, and Risk Factors for Conversion to Total Hip Arthroplasty After Revision Hip Arthroscopic Surgery in Obese Patients: Results at a Minimum 5-Year Follow-up.

Maldonado D, Lee M, Kyin C, Jimenez A, Owens J, Perez-Padilla P Orthop J Sports Med. 2023; 11(4):23259671231154921.

PMID: 37056451 PMC: 10087662. DOI: 10.1177/23259671231154921.

References
1.
Domb B, Chen S, Go C, Shapira J, Rosinsky P, Meghpara M . Predictors of Clinical Outcomes After Hip Arthroscopy: 5-Year Follow-up Analysis of 1038 Patients. Am J Sports Med. 2020; 49(1):112-120. DOI: 10.1177/0363546520968896. View

2.
Beck E, Nwachukwu B, Kunze K, Chahla J, Nho S . How Can We Define Clinically Important Improvement in Pain Scores After Hip Arthroscopy for Femoroacetabular Impingement Syndrome? Minimum 2-Year Follow-up Study. Am J Sports Med. 2019; 47(13):3133-3140. DOI: 10.1177/0363546519877861. View

3.
Ali M, Prieto-Alhambra D, Lopes L, Ramos D, Bispo N, Ichihara M . Propensity Score Methods in Health Technology Assessment: Principles, Extended Applications, and Recent Advances. Front Pharmacol. 2019; 10:973. PMC: 6760465. DOI: 10.3389/fphar.2019.00973. View

4.
Jimenez A, Owens J, Shapira J, Saks B, Ankem H, Sabetian P . Hip Capsular Management in Patients With Femoroacetabular Impingement or Microinstability: A Systematic Review of Biomechanical Studies. Arthroscopy. 2021; 37(8):2642-2654. DOI: 10.1016/j.arthro.2021.04.004. View

5.
Seldes R, Tan V, Hunt J, Katz M, Winiarsky R, Fitzgerald Jr R . Anatomy, histologic features, and vascularity of the adult acetabular labrum. Clin Orthop Relat Res. 2001; (382):232-40. DOI: 10.1097/00003086-200101000-00031. View